Ribitol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Ribitol
DrugBank Accession Number
DB14704
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 152.1458
Monoisotopic: 152.068473494
Chemical Formula
C5H12O5
Synonyms
  • (2R,3s,4S)-pentane-1,2,3,4,5-pentol
  • Adonitol
  • D-Adonitol
  • D-Ribitol
  • L-ribitol

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
353ZQ9TVDA
CAS number
488-81-3
InChI Key
HEBKCHPVOIAQTA-ZXFHETKHSA-N
InChI
InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5-
IUPAC Name
(2R,3s,4S)-pentane-1,2,3,4,5-pentol
SMILES
OC[C@H](O)[C@H](O)[C@H](O)CO

References

General References
Not Available
Human Metabolome Database
HMDB0000508
ChemSpider
10254628
ChEBI
15963
ChEMBL
CHEMBL3137744
ZINC
ZINC000100014205
PDBe Ligand
RB0
Wikipedia
Ribitol
PDB Entries
4f2d / 4q0s / 5iai / 6kaj / 6kam / 7cyy

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3RecruitingTreatmentLimb-Girdle Muscular Dystrophy Type 2I (LGMD2I)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility664.0 mg/mLALOGPS
logP-2.5ALOGPS
logP-3.1Chemaxon
logS0.64ALOGPS
pKa (Strongest Acidic)12.76Chemaxon
pKa (Strongest Basic)-3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count5Chemaxon
Polar Surface Area101.15 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity32.44 m3·mol-1Chemaxon
Polarizability14.38 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (5 TMS)GC-MSsplash10-0fr2-0930000000-5a1a8471040df361537c
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-0gba-0940000000-39c5ee90545f38856669
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (5 TMS)GC-MSsplash10-00di-8941000000-a1eac40beaba679b545b
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (5 TMS)GC-MSsplash10-00di-8930000000-85527d43cd5f10f959a8
GC-MS Spectrum - GC-MS (5 TMS)GC-MSsplash10-0gb9-0962000000-9c177252fb79fd04ff8c
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-03dl-9100000000-738016d8bd07caed9ccc
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0fr2-0930000000-5a1a8471040df361537c
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0gba-0940000000-39c5ee90545f38856669
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00di-8941000000-a1eac40beaba679b545b
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00di-8930000000-85527d43cd5f10f959a8
GC-MS Spectrum - GC-MSGC-MSsplash10-0gb9-0962000000-9c177252fb79fd04ff8c
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-00kb-9200000000-1c9444c33ee213e4aa4f
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-05mo-9000000000-baf46067df2ebf3b854c
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-0006-9000000000-3276d3005611fd3d415c
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-0udi-0901000000-7db5e452cb762f33fd3a
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-014j-8900000000-5ee7c2252ae88c5c0198
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-001i-0900000000-47c7512c4671bb121a01
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-001i-1900000000-b984613919de5add093c
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-0ufr-0901000000-616311fa40559ac618da
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-014j-7900000000-c947bd6b615b2019d255
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-000i-0900000000-c7e6bce3675a8cd1566b
LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , PositiveLC-MS/MSsplash10-0a4i-0900000000-419f37e184ec82e4c123
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-014j-8900000000-e69cc8758936cd2cbcea
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-001i-0900000000-d6447ee4c80f85c44fef
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-001i-1900000000-67203d89ca337c3cd9d1
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-014j-7900000000-867bbfc363a4790dadc1
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-000i-0900000000-c7e6bce3675a8cd1566b
LC-MS/MS Spectrum - LC-ESI-ITFT , positiveLC-MS/MSsplash10-0a4i-0900000000-419f37e184ec82e4c123
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-2900000000-6c118583e36a682a7447
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00di-9200000000-d903335b43289aad81e5
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-01ox-9100000000-f918bfaf4772d11f22f5
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0ab9-9000000000-fae56ff80f55c755cce9
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0007-9000000000-dfd220fad61a1a07bd1e
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-d85f91f3d336558cf063
1H NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-129.0329069
predicted
DarkChem Lite v0.1.0
[M-H]-129.2343069
predicted
DarkChem Lite v0.1.0
[M-H]-132.86786
predicted
DeepCCS 1.0 (2019)
[M+H]+129.4033069
predicted
DarkChem Lite v0.1.0
[M+H]+130.1322069
predicted
DarkChem Lite v0.1.0
[M+H]+135.26344
predicted
DeepCCS 1.0 (2019)
[M+Na]+129.4478069
predicted
DarkChem Lite v0.1.0
[M+Na]+129.5693069
predicted
DarkChem Lite v0.1.0
[M+Na]+141.56102
predicted
DeepCCS 1.0 (2019)

Drug created at September 24, 2018 16:10 / Updated at June 12, 2020 16:53